Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma

Selective targeting of anticancer drugs to the tumor site is beneficial in the pharmacotherapy of hepatocellular carcinoma (HCC). This study evaluated the prospective of galactosylated chitosan nanoparticles as a liver-specific carrier to improve the therapeutic efficacy of gemcitabine in HCC by tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Anroop B., Shah, Jigar, Al-Dhubiab, Bandar E., Patel, Snehal S., Morsy, Mohamed A., Patel, Vimal, Chavda, Vishal, Jacob, Shery, Sreeharsha, Nagaraja, Shinu, Pottathil, Attimarad, Mahesh, Venugopala, Katharigatta N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943439/
https://www.ncbi.nlm.nih.gov/pubmed/31847085
http://dx.doi.org/10.3390/molecules24244566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943439/
https://www.ncbi.nlm.nih.gov/pubmed/31847085
http://dx.doi.org/10.3390/molecules24244566

Ejemplares similares